| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Prairie Operating Co.
13G/A
Amendment 1
PROP · 739650109
|
0% |
11/14/2025
Event 11/14/2025
|
|||
| Bristol Investment Fund, Ltd. | 0% | ||||
| Bristol Capital, LLC | 0% | ||||
| Paul Kessler | 0% | ||||
|
GT Biopharma, Inc.
13G/A
Amendment 18
GTBP · 36254L308
|
2.4% |
6/2/2025
Event 5/29/2025
|
|||
| Bristol Investment Fund, Ltd. | 2.4% | ||||
| Bristol Capital, LLC | 4.8% | ||||
|
Prairie Operating Co.
13G
PROP · 739650109
|
6.4% |
4/2/2025
Event 4/1/2025
|
|||
| Bristol Investment Fund, Ltd. | 2.7% | ||||
| Bristol Capital, LLC | 6.4% | ||||
| Paul Kessler | 0% | ||||
|
Prairie Operating Co.
13D/A
Amendment 19
PROP · 739650109
|
4.8% |
2/14/2025
Event 12/31/2024
|
|||
| Bristol Investment Fund, Ltd. | 4.8% | ||||
| Bristol Capital, LLC | 1.6% | ||||
| Paul Kessler | 0% | ||||
| Bristol Capital Advisors Profit Sharing Plan | 0% | ||||
|
Nuuve Holding Corp.
13G/A
Amendment 1
NVVE · 67079Y308
|
7.7% |
2/13/2025
Event 2/10/2025
|
|||
| Bristol Investment Fund, Ltd. | 7.7% | ||||
| Bristol Capital, LLC | 0% | ||||
|
Nuvve Holding Corp.
13G
NVVE · 67079Y308
|
5.6% |
1/17/2025
Event 1/17/2025
|
|||
| Bristol Investment Fund, Ltd. | 4.3% | ||||
| Bristol Capital, LLC | 5.6% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.